Aptevo Therapeutics Inc. (APVO) Return on equity 2016–2023
Aptevo Therapeutics Inc. (APVO) return on equity by fiscal year — reported net income divided by year-end shareholders’ equity.
-96.9%FY2023 · since FY2016: -126.9% → -96.9%
| Fiscal year | Value | YoY |
|---|---|---|
| FY2023 | -96.9% | -757.0 pp |
| FY2022 | 660.1% | +831.6 pp |
| FY2021 | -171.5% | -21.6 pp |
| FY2020 | -149.9% | -16.9 pp |
| FY2019 | -133.0% | -67.6 pp |
| FY2018 | -65.4% | -79.2 pp |
| FY2017 | 13.8% | +140.6 pp |
| FY2016 | -126.9% | — |
ROE = reported net income ÷ reported year-end shareholders’ equity for the same fiscal year. Heavy buybacks shrink equity and can push ROE very high (or negative-equity years drop out).
Source: SEC XBRL filings · For reference only · Not investment advice